A detailed history of Israel Englander (Millennium Management LLC) transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 116,093 shares of ANIK stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
116,093
Previous 327,642 64.57%
Holding current value
$3.2 Million
Previous $7.42 Million 60.29%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$21.95 - $26.42 $4.64 Million - $5.59 Million
-211,549 Reduced 64.57%
116,093 $2.95 Million
Q4 2023

Feb 14, 2024

BUY
$18.47 - $23.3 $3.64 Million - $4.59 Million
196,866 Added 150.54%
327,642 $7.42 Million
Q2 2023

Aug 14, 2023

BUY
$25.16 - $28.86 $3.09 Million - $3.54 Million
122,659 Added 1511.14%
130,776 $3.4 Million
Q1 2023

May 15, 2023

SELL
$25.91 - $32.1 $3.16 Million - $3.91 Million
-121,844 Reduced 93.75%
8,117 $233,000
Q4 2022

Feb 14, 2023

BUY
$23.85 - $31.91 $2.86 Million - $3.83 Million
120,092 Added 1216.86%
129,961 $3.85 Million
Q3 2022

Nov 14, 2022

SELL
$21.74 - $24.68 $586,893 - $666,261
-26,996 Reduced 73.23%
9,869 $235,000
Q2 2022

Aug 15, 2022

BUY
$20.4 - $25.53 $752,046 - $941,163
36,865 New
36,865 $823,000
Q1 2022

May 16, 2022

SELL
$24.7 - $36.54 $749,027 - $1.11 Million
-30,325 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$35.83 - $45.03 $32,927 - $41,382
-919 Reduced 2.94%
30,325 $1.09 Million
Q3 2021

Nov 15, 2021

SELL
$38.75 - $44.47 $511,810 - $587,359
-13,208 Reduced 29.71%
31,244 $1.33 Million
Q2 2021

Aug 16, 2021

SELL
$39.42 - $48.08 $3.11 Million - $3.79 Million
-78,874 Reduced 63.96%
44,452 $1.92 Million
Q1 2021

May 17, 2021

BUY
$32.49 - $45.96 $3.22 Million - $4.55 Million
99,036 Added 407.72%
123,326 $5.03 Million
Q4 2020

Feb 16, 2021

BUY
$32.59 - $45.26 $791,611 - $1.1 Million
24,290 New
24,290 $1.1 Million
Q2 2020

Aug 14, 2020

SELL
$27.83 - $37.73 $1.65 Million - $2.23 Million
-59,236 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$22.38 - $54.06 $823,091 - $1.99 Million
-36,778 Reduced 38.3%
59,236 $1.71 Million
Q4 2019

Feb 14, 2020

SELL
$51.85 - $73.36 $4.97 Million - $7.04 Million
-95,947 Reduced 49.98%
96,014 $4.98 Million
Q3 2019

Nov 14, 2019

SELL
$40.05 - $57.47 $3.88 Million - $5.57 Million
-96,864 Reduced 33.54%
191,961 $10.5 Million
Q2 2019

Aug 15, 2019

BUY
$30.3 - $41.14 $1.89 Million - $2.56 Million
62,268 Added 27.48%
288,825 $11.7 Million
Q1 2019

May 14, 2019

BUY
$29.37 - $40.49 $1.06 Million - $1.46 Million
36,009 Added 18.9%
226,557 $6.85 Million
Q4 2018

Feb 14, 2019

BUY
$30.16 - $43.0 $3 Million - $4.27 Million
99,387 Added 109.02%
190,548 $6.4 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $42.51 $897,112 - $1.16 Million
27,326 Added 42.81%
91,161 $3.85 Million
Q2 2018

Aug 14, 2018

BUY
$28.77 - $48.27 $587,483 - $985,673
20,420 Added 47.03%
63,835 $2.04 Million
Q1 2018

May 15, 2018

BUY
$49.22 - $68.43 $1.95 Million - $2.71 Million
39,554 Added 1024.45%
43,415 $2.16 Million
Q4 2017

Feb 14, 2018

SELL
$52.14 - $59.94 $207,621 - $238,681
-3,982 Reduced 50.77%
3,861 $208,000
Q3 2017

Nov 14, 2017

BUY
$51.16 - $58.21 $401,247 - $456,541
7,843
7,843 $455,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $402M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.